abstract |
A diagnostic test for preclinical and clinical Alzheimer's disease is based on plasma levels of Aβ 40 , Aβ 42 , their ratio, or their rate of entry following administration of antibodies that sequester Aβ. Alterations of any of these parameters from control values identifies preclinical or clinical Alzheimer's disease. |